Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Mercy Hospital Saint Louis
mi
from
Saint Louis, MO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Mercy Hospital Saint Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Cancer Research for the Ozarks NCORP
mi
from
Springfield, MO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Cancer Research for the Ozarks NCORP
mi
from
Springfield, MO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Billings Clinic Cancer Center
mi
from
Billings, MT
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Billings Clinic Cancer Center
mi
from
Billings, MT
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Montana Cancer Consortium NCORP
mi
from
Billings, MT
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Montana Cancer Consortium NCORP
mi
from
Billings, MT
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Frontier Cancer Center and Blood Institute-Billings
mi
from
Billings, MT
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Frontier Cancer Center and Blood Institute-Billings
mi
from
Billings, MT
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Saint Peter's Community Hospital
mi
from
Helena, MT
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Saint Peter's Community Hospital
mi
from
Helena, MT
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Montana Cancer Specialists
mi
from
Missoula, MT
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Montana Cancer Specialists
mi
from
Missoula, MT
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
CHI Health Good Samaritan
mi
from
Kearney, NE
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
CHI Health Good Samaritan
mi
from
Kearney, NE
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Missouri Valley Cancer Consortium
mi
from
Omaha, NE
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Alegent Health Immanuel Medical Center
mi
from
Omaha, NE
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Alegent Health Immanuel Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Inspira Medical Center Vineland
mi
from
Vineland, NJ
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Inspira Medical Center Vineland
mi
from
Vineland, NJ
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Hematology Oncology Associates of Central New York-Auburn
mi
from
Auburn, NY
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Hematology Oncology Associates of Central New York-Auburn
mi
from
Auburn, NY
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Columbia University Herbert Irving Cancer Center
mi
from
New York, NY
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Columbia University Herbert Irving Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Hematology Oncology Associates of Central New York-Rome
mi
from
Rome, NY
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Hematology Oncology Associates of Central New York-Rome
mi
from
Rome, NY
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
State University of New York Upstate Medical University
mi
from
Syracuse, NY
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Hematology Oncology Associates of Central New York-Onondaga Hill
mi
from
Syracuse, NY
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Hematology Oncology Associates of Central New York-Onondaga Hill
mi
from
Syracuse, NY
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Novant Health Presbyterian Medical Center
mi
from
Charlotte, NC
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Novant Health Presbyterian Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Southern Oncology Specialists-Charlotte
mi
from
Charlotte, NC
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Southern Oncology Specialists-Charlotte
mi
from
Charlotte, NC
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Hendersonville Hematology and Oncology at Pardee
mi
from
Hendersonville, NC
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Hendersonville Hematology and Oncology at Pardee
mi
from
Hendersonville, NC
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Margaret R Pardee Memorial Hospital
mi
from
Hendersonville, NC
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Margaret R Pardee Memorial Hospital
mi
from
Hendersonville, NC
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Southern Oncology Specialists-Huntersville
mi
from
Huntersville, NC
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Southern Oncology Specialists-Huntersville
mi
from
Huntersville, NC
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Novant Health Cancer Specialists-Matthews
mi
from
Matthews, NC
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Novant Health Cancer Specialists-Matthews
mi
from
Matthews, NC
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Lake Norman Hematology Oncology Specialists-Mooresville
mi
from
Mooresville, NC
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Lake Norman Hematology Oncology Specialists-Mooresville
mi
from
Mooresville, NC
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Southeast Clinical Oncology Research (SCOR) Consortium NCORP
mi
from
Winston-Salem, NC
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Southeast Clinical Oncology Research (SCOR) Consortium NCORP
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Columbus NCI Community Oncology Research Program
mi
from
Columbus, OH
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Columbus NCI Community Oncology Research Program
mi
from
Columbus, OH
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Mount Carmel Health Center West
mi
from
Columbus, OH
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Mount Carmel Health Center West
mi
from
Columbus, OH
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Delaware Radiation Oncology
mi
from
Delaware, OH
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Delaware Radiation Oncology
mi
from
Delaware, OH
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Lancaster Radiation Oncology
mi
from
Lancaster, OH
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Lancaster Radiation Oncology
mi
from
Lancaster, OH
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Newark Radiation Oncology
mi
from
Newark, OH
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Newark Radiation Oncology
mi
from
Newark, OH
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Genesis Healthcare System Cancer Care Center
mi
from
Zanesville, OH
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Genesis Healthcare System Cancer Care Center
mi
from
Zanesville, OH
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Providence Saint Vincent Medical Center
mi
from
Portland, OR
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Providence Saint Vincent Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Greenville Health System Cancer Institute/Eastside
mi
from
Greenville, SC
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Greenville Health System Cancer Institute/Eastside
mi
from
Greenville, SC
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Spartanburg Medical Center
mi
from
Spartanburg, SC
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Spartanburg Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
M D Anderson Cancer Center
mi
from
Houston, TX
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Methodist Hospital System
mi
from
Houston, TX
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Methodist Hospital System
mi
from
Houston, TX
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
EvergreenHealth Medical Center
mi
from
Kirkland, WA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
EvergreenHealth Medical Center
mi
from
Kirkland, WA
Click here to add this to my saved trials
A Trial for Treatment of Stage IIIB or IV Non-Small Cell Lung Cancer
Multicenter, Open-Label, Randomized, Phase II Trial of Docetaxel, Carboplatin and Bevacizumab as First-Line Treatment, Followed by Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Second Line Treatment of Stage IIIB or IV NSCLC
Status: Enrolling
Updated:  11/22/2017
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
A Trial for Treatment of Stage IIIB or IV Non-Small Cell Lung Cancer
Multicenter, Open-Label, Randomized, Phase II Trial of Docetaxel, Carboplatin and Bevacizumab as First-Line Treatment, Followed by Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Second Line Treatment of Stage IIIB or IV NSCLC
Status: Enrolling
Updated: 11/22/2017
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
A Randomized Controlled Trial of Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
Status: Enrolling
Updated:  11/22/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
A Randomized Controlled Trial of Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
Status: Enrolling
Updated: 11/22/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
A Randomized Controlled Trial of Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
Status: Enrolling
Updated:  11/22/2017
Massachusetts General Hospital
mi
from
Boston, MA
Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
A Randomized Controlled Trial of Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
Status: Enrolling
Updated: 11/22/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
A Randomized Controlled Trial of Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
Status: Enrolling
Updated:  11/22/2017
Mass General/North Shore Cancer Center
mi
from
Danvers, MA
Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
A Randomized Controlled Trial of Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
Status: Enrolling
Updated: 11/22/2017
Mass General/North Shore Cancer Center
mi
from
Danvers, MA
Click here to add this to my saved trials
Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
A Randomized Controlled Trial of Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
Status: Enrolling
Updated:  11/22/2017
University of Southern California- Keck School of Medicine
mi
from
Los Angeles, CA
Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
A Randomized Controlled Trial of Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
Status: Enrolling
Updated: 11/22/2017
University of Southern California- Keck School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
A Randomized Controlled Trial of Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
Status: Enrolling
Updated:  11/22/2017
VA Boston Healthcare System
mi
from
Boston, MA
Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
A Randomized Controlled Trial of Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
Status: Enrolling
Updated: 11/22/2017
VA Boston Healthcare System
mi
from
Boston, MA
Click here to add this to my saved trials
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia
Clinical Study of Ursodeoxycholic Acid in Barrett's Patients
Status: Enrolling
Updated:  11/22/2017
Southern Arizona Veterans Affairs Health Center
mi
from
Tucson, AZ
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia
Clinical Study of Ursodeoxycholic Acid in Barrett's Patients
Status: Enrolling
Updated: 11/22/2017
Southern Arizona Veterans Affairs Health Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia
Clinical Study of Ursodeoxycholic Acid in Barrett's Patients
Status: Enrolling
Updated:  11/22/2017
University of Arizona Health Sciences Center
mi
from
Tucson, AZ
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia
Clinical Study of Ursodeoxycholic Acid in Barrett's Patients
Status: Enrolling
Updated: 11/22/2017
University of Arizona Health Sciences Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia
Clinical Study of Ursodeoxycholic Acid in Barrett's Patients
Status: Enrolling
Updated:  11/22/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia
Clinical Study of Ursodeoxycholic Acid in Barrett's Patients
Status: Enrolling
Updated: 11/22/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia
Clinical Study of Ursodeoxycholic Acid in Barrett's Patients
Status: Enrolling
Updated:  11/22/2017
Arizona Cancer Center-North Campus
mi
from
Tucson, AZ
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia
Clinical Study of Ursodeoxycholic Acid in Barrett's Patients
Status: Enrolling
Updated: 11/22/2017
Arizona Cancer Center-North Campus
mi
from
Tucson, AZ
Click here to add this to my saved trials
Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor
Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor
Status: Enrolling
Updated:  11/24/2017
NYU School of Medicine
mi
from
New York, NY
Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor
Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor
Status: Enrolling
Updated: 11/24/2017
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Vaccination With Tetanus and KLH to Assess Immune Responses.
Vaccination With Tetanus Toxoid and Keyhole Limpet Hemocyanin (KLH) to Assess Antigen-Specific Immune Responses
Status: Enrolling
Updated:  11/27/2017
Division of Hematology, Oncology, and Transplantation 420 Delaware St., SE, Box 806 Mayo
mi
from
Minneapolis, MN
Vaccination With Tetanus and KLH to Assess Immune Responses.
Vaccination With Tetanus Toxoid and Keyhole Limpet Hemocyanin (KLH) to Assess Antigen-Specific Immune Responses
Status: Enrolling
Updated: 11/27/2017
Division of Hematology, Oncology, and Transplantation 420 Delaware St., SE, Box 806 Mayo
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Clinical Trial of Trametes Versicolor in Women With Breast Cancer
Phase I Clinical Trial of Trametes Versicolor in Women With Breast Cancer
Status: Enrolling
Updated:  11/27/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Clinical Trial of Trametes Versicolor in Women With Breast Cancer
Phase I Clinical Trial of Trametes Versicolor in Women With Breast Cancer
Status: Enrolling
Updated: 11/27/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Clinical Trial of Trametes Versicolor in Women With Breast Cancer
Phase I Clinical Trial of Trametes Versicolor in Women With Breast Cancer
Status: Enrolling
Updated:  11/27/2017
Bastyr University
mi
from
Kenmore, WA
Clinical Trial of Trametes Versicolor in Women With Breast Cancer
Phase I Clinical Trial of Trametes Versicolor in Women With Breast Cancer
Status: Enrolling
Updated: 11/27/2017
Bastyr University
mi
from
Kenmore, WA
Click here to add this to my saved trials